Documents
-
- Download
- Title pages_Contents
- open access
-
- Download
- Part I : Chapter 2
- open access
- Full text at publishers site
-
- Download
- Part I : Chapter 3
- open access
- Full text at publishers site
-
- Download
- Part I : Chapter 4
- open access
- Full text at publishers site
-
- Download
- Part I : Chapter 5
- open access
- Full text at publishers site
-
- Download
- Part I : Chapter 6
- open access
- Full text at publishers site
-
- Download
- Part I : Chapter 7
- open access
- Full text at publishers site
-
- Download
- Part II : Chapter 8
- open access
- Full text at publishers site
-
- Download
- Part II : Chapter 9
- open access
- Full text at publishers site
-
- Download
- Part II : Chapter 10
- open access
-
- Download
- Part II : Chapter 11
- open access
- Full text at publishers site
-
- Download
- Part II : Chapter 12
- open access
-
- Download
- Summary in English
- open access
-
- Download
- Summary in Dutch
- open access
-
- Download
- Propositions
- open access
In Collections
This item can be found in the following collections:
Unravelling the anti-carbamylated protein antibody response in rheumatoid arthritis
Although quite some data is available on anti-CarP antibodies, several questions remain unanswered, including the reproducibility of the clinical data on anti-CarP antibodies, such as their presence before disease onset and association with joint damage. It is also unknown whether these findings can be expanded to non-caucasian populations. Furthermore, it is unclear how anti-CarP antibodies are induced, what proteins they recognize, whether they are able to recognize multiple carbamylated proteins and what the characteristics of these autoantibodies are. Here, some of these questions will be answered.
In this thesis, I will first discuss the clinical implications of the presence of anti-CarP antibodies compared to RA-specific autoantibodies in both RA patients other relevant conditions (chapters 2 till 7). This is followed by more detailed investigations into the characteristics of anti-CarP antibodies and their antigens (chapters 8 till 12).
...
Show moreAlthough quite some data is available on anti-CarP antibodies, several questions remain unanswered, including the reproducibility of the clinical data on anti-CarP antibodies, such as their presence before disease onset and association with joint damage. It is also unknown whether these findings can be expanded to non-caucasian populations. Furthermore, it is unclear how anti-CarP antibodies are induced, what proteins they recognize, whether they are able to recognize multiple carbamylated proteins and what the characteristics of these autoantibodies are. Here, some of these questions will be answered.In this thesis, I will first discuss the clinical implications of the presence of anti-CarP antibodies compared to RA-specific autoantibodies in both RA patients other relevant conditions (chapters 2 till 7). This is followed by more detailed investigations into the characteristics of anti-CarP antibodies and their antigens (chapters 8 till 12). Show less
- All authors
- Verheul, M.K.
- Supervisor
- Toes, R.E.M.; Huizinga, T.W.J.
- Co-supervisor
- Trouw, L.A.
- Committee
- Helm, A.H.M. van der; Bakker, J.A.; Pruijn, G.J.M.; Hamann, D.
- Qualification
- Doctor (dr.)
- Awarding Institution
- Faculty of Medicine, Leiden Uiversity Medical Center (LUMC) , Leiden University
- Date
- 2019-01-09
- ISBN (print)
- 9789463234573